1. Home
  2. KYTX vs ABAT Comparison

KYTX vs ABAT Comparison

Compare KYTX & ABAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYTX
  • ABAT
  • Stock Information
  • Founded
  • KYTX 2018
  • ABAT 2011
  • Country
  • KYTX United States
  • ABAT United States
  • Employees
  • KYTX N/A
  • ABAT N/A
  • Industry
  • KYTX
  • ABAT Metal Mining
  • Sector
  • KYTX
  • ABAT Basic Materials
  • Exchange
  • KYTX NYSE
  • ABAT Nasdaq
  • Market Cap
  • KYTX 92.1M
  • ABAT 87.2M
  • IPO Year
  • KYTX 2024
  • ABAT N/A
  • Fundamental
  • Price
  • KYTX $3.07
  • ABAT $1.30
  • Analyst Decision
  • KYTX Strong Buy
  • ABAT
  • Analyst Count
  • KYTX 5
  • ABAT 0
  • Target Price
  • KYTX $19.00
  • ABAT N/A
  • AVG Volume (30 Days)
  • KYTX 415.4K
  • ABAT 889.8K
  • Earning Date
  • KYTX 08-11-2025
  • ABAT 05-16-2025
  • Dividend Yield
  • KYTX N/A
  • ABAT N/A
  • EPS Growth
  • KYTX N/A
  • ABAT N/A
  • EPS
  • KYTX N/A
  • ABAT N/A
  • Revenue
  • KYTX N/A
  • ABAT $1,857,877.00
  • Revenue This Year
  • KYTX N/A
  • ABAT $31,748.62
  • Revenue Next Year
  • KYTX N/A
  • ABAT N/A
  • P/E Ratio
  • KYTX N/A
  • ABAT N/A
  • Revenue Growth
  • KYTX N/A
  • ABAT N/A
  • 52 Week Low
  • KYTX $1.78
  • ABAT $0.73
  • 52 Week High
  • KYTX $11.40
  • ABAT $4.11
  • Technical
  • Relative Strength Index (RSI)
  • KYTX 55.92
  • ABAT 47.68
  • Support Level
  • KYTX $2.86
  • ABAT $1.29
  • Resistance Level
  • KYTX $2.82
  • ABAT $1.40
  • Average True Range (ATR)
  • KYTX 0.31
  • ABAT 0.07
  • MACD
  • KYTX -0.03
  • ABAT -0.01
  • Stochastic Oscillator
  • KYTX 40.94
  • ABAT 16.00

About KYTX KYVERNA THERAPEUTICS INC

Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.

About ABAT American Battery Technology Company

American Battery Technology Co is engaged in lithium-ion battery recycling, battery metals and material extraction, and resource production. It is a battery metals company producing low-cost battery metals with a commitment to closed-loop, clean energy technologies.

Share on Social Networks: